National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

alprostadil
The naturally occuring prostaglandin E1 (PGE1) which displays a variety of pharmacologic actions. Alprostadil is a potent vasodilator agent that increases peripheral blood flow, inhibits platelet aggregation, and induces bronchodilation. Used in the treatment of erectile dysfunction, this agent produces corporal smooth muscle relaxation by binding to PGE receptors, resulting in the activation of adenylate cyclase and the subsequent accumulation of 3'5'-cAMP. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:prostaglandin E1
US brand names:Caverject
MUSE
Abbreviation:PGE1
Chemical structure name:(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid



Previous:alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine, alpha-1,3-galactosyltransferase-expressing allogeneic pancreatic tumor cell vaccine, alpha-Gal glycosphingolipids, alpha-galactosylceramide-pulsed autologous dendritic cells, alprazolam
Next:Althose, altretamine, alum adjuvant, ALVAC(2) melanoma multi-antigen therapeutic vaccine, ALVAC-hB7.1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov